Literature DB >> 6803328

Bacillus cereus panophthalmitis: source of the organism.

D Shamsuddin, C U Tuazon, C Levy, J Curtin.   

Abstract

Serious infections with the "nonpathogenic" Bacillus species are increasingly being recognized, especially in drug abusers. Cases of panophthalmitis secondary to infection with Bacillus cereus, with and without associated bacteremia, have been reported. Three drug abusers with panophthalmitis seen in our hospitals during a three-year period are described, and the similar cases reported in the literature are reviewed. The syndrome is characterized by an acute onset with a rapid fulminating course that eventually leads to enucleation or evisceration of the eye. The pathogenic mechanism is unknown, but is probably related to the production of toxin (lecithinase) by B. cereus. Clindamycin appears to be the antibiotic of choice in the treatment of this infection. In order to identify a possible source of the organism, 59 samples of heroin and injection paraphernalia were cultured. Twenty cultures yielded organisms; Bacillus species were the predominant isolates. Thirty-eight percent of the isolates were identified as B. cereus. Thus, infections caused by Bacillus species in drug abusers can probably be associated with intravenous heroin abuse because heroin mixtures and injection paraphernalia are frequently contaminated with this organism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6803328     DOI: 10.1093/clinids/4.1.97

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  25 in total

Review 1.  On the safety of Bacillus subtilis and B. amyloliquefaciens: a review.

Authors:  A S de Boer; B Diderichsen
Journal:  Appl Microbiol Biotechnol       Date:  1991-10       Impact factor: 4.813

2.  Emerging and Underrecognized Complications of Illicit Drug Use.

Authors:  Alysse G Wurcel; Elisabeth A Merchant; Roger P Clark; David R Stone
Journal:  Clin Infect Dis       Date:  2015-08-12       Impact factor: 9.079

3.  Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis.

Authors:  Andrea L Moyer; Raniyah T Ramadan; Billy D Novosad; Roger Astley; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-05       Impact factor: 4.799

4.  In vitro susceptibilities of ocular Bacillus cereus isolates to clindamycin, gentamicin, and vancomycin alone or in combination.

Authors:  J W Gigantelli; J Torres Gomez; M S Osato
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

Review 5.  Role of Neurochemicals in the Interaction between the Microbiota and the Immune and the Nervous System of the Host Organism.

Authors:  Alexander V Oleskin; Boris A Shenderov; Vladimir S Rogovsky
Journal:  Probiotics Antimicrob Proteins       Date:  2017-09       Impact factor: 4.609

Review 6.  Bacillus cereus endophthalmitis.

Authors:  D B David; G R Kirkby; B A Noble
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

7.  A case of septicaemia caused by Bacillus cereus.

Authors:  P Casella; N Monzani
Journal:  Eur J Clin Microbiol       Date:  1984-02       Impact factor: 3.267

8.  Successful treatment of Bacillus cereus infection with ciprofloxacin.

Authors:  A D Gascoigne; J Richards; K Gould; G J Gibson
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

9.  Differentiation of Bacillus anthracis and other Bacillus species by lectins.

Authors:  H B Cole; J W Ezzell; K F Keller; R J Doyle
Journal:  J Clin Microbiol       Date:  1984-01       Impact factor: 5.948

10.  Non-gastrointestinal Bacillus cereus infections: an analysis of exotoxin production by strains isolated over a two-year period.

Authors:  P C Turnbull; J M Kramer
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.